Literature DB >> 7116651

Evaluation of a solid-phase immunoradiometric assay (IRMA) for serum thyroglobulin: effect of anti-thyroglobulin autoantibody.

S Mariotti, C Cupini, C Giani, R Lari, E Rolleri, A Falco, M Marchisio, A Pinchera.   

Abstract

Mesh：

Substances：

Year:  1982        PMID： 7116651     DOI： 10.1016/0009-8981(82)90181-4

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN： 0009-8981            Impact factor:   3.786


× No keyword cloud information.
  8 in total

1.  Usefulness of the combined antithyroglobulin antibodies and thyroglobulin assay in the follow-up of patients with differentiated thyroid cancer.

Authors:  D Rubello; M E Girelli; D Casara; M Piccolo; A Perin; B Busnardo
Journal:  J Endocrinol Invest       Date:  1990-10       Impact factor: 4.256

Review 2.  Serum thyroglobulin (Tg) in presence of thyroglobulin autoantibodies (TgAb). Clinical and methodological relevance of the interaction between Tg and TgAb in vitro and in vivo.

Authors:  U Feldt-Rasmussen; A K Rasmussen
Journal:  J Endocrinol Invest       Date:  1985-12       Impact factor: 4.256

3.  A new immunoradiometric assay (IRMA) system for thyroglobulin measurement in the follow-up of thyroid cancer patients.

Authors:  M Schlumberger; P Fragu; P Gardet; J Lumbroso; D Violot; C Parmentier
Journal:  Eur J Nucl Med       Date:  1991

4.  European interlaboratory comparison of serum thyroglobulin measurement.

Authors:  U Feldt-Rasmussen; M Schlumberger
Journal:  J Endocrinol Invest       Date:  1988-03       Impact factor: 4.256

5.  Immunoreactive thyroglobulin in sera and saliva of patients with various thyroid disorders: role of autoantibodies.

Authors:  A J Van Herle; P D Rosenblit; T L Van Herle; P Van Herle; M Greipel; K Kellett
Journal:  J Endocrinol Invest       Date:  1989-03       Impact factor: 4.256

6.  Serum tissue polypeptide antigen (TPA) in thyroid cancer.

Authors:  E Martino; G Bambini; F Aghini-Lombardi; E Motz; F Pacini; R Lari; L Baschieri; A Pinchera
Journal:  J Endocrinol Invest       Date:  1984-06       Impact factor: 4.256

7.  Recurrent/metastatic thyroid carcinomas false negative for serum thyroglobulin but positive by posttherapy I-131 whole body scans.

Authors:  Eun-Kyung Park; June-Key Chung; Il Han Lim; Do Joon Park; Dong Soo Lee; Myung Chul Lee; Bo Youn Cho
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-09-09       Impact factor: 9.236

Review 8.  How sensitive (second-generation) thyroglobulin measurement is changing paradigms for monitoring patients with differentiated thyroid cancer, in the absence or presence of thyroglobulin autoantibodies.

Authors:  Carole Spencer; Jonathan LoPresti; Shireen Fatemi
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2014-10       Impact factor: 3.243
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.